Tag: anti-SEMA4D

January 17, 2019

Vaccinex Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503

Vaccinex (Nasdaq:VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and...
December 12, 2018

Vaccinex Preclinical Data Published in Cancer Immunology Research

Vaccinex (Nasdaq:VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and...